Related Experiment Video
Updated: May 29, 2026

Purification of Transcripts and Metabolites from Drosophila Heads
Published on: March 15, 2013
Role of the proteasome in fly models of neurodegeneration
Chun-Hung Yeh1, Marlon Jansen, Thomas Schmidt-Glenewinkel
1Department of Biological Sciences, Hunter College of City University of New York, New York, NY, USA.
Abstract:
Most neurodegenerative disorders are associated with aggregates of ubiquitinated proteins, such as Lewy bodies in Parkinson's disease and neurofibrillary tangles in Alzheimer's disease. Although the etiology of the sporadic forms of these disorders remains elusive, these observations support our idea that proteasome impairment is an important risk factor in neurodegeneration. Proteasome dysfunction is, thus, expected to be a pivotal link between environmental and genetic factors that are implicated in triggering neurodegeneration. Here, we discuss the rationale for the use of Drosophila as a model system for the study of neurodegeneration. As an example of a specific application of this model system, we provide experimental methodology for the assessment of proteasome function by a nondenaturing gel assay, by Western blotting, as well as measurement of ATP levels which are critical for proteasome function. In addition, we discuss immunocytochemical approaches for the study of both the larval and adult Drosophila nervous system.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

